News About: Pharm. Industry
Stem cells bring life to Korea’s biotech industry
Korea has steadily regained its place as a stem cell research powerhouse, relaxing regulations and producing the world’s first three commercialized stem cell treatments.
Global demand for stem cell therapies is for...
KPMA favors ex-officials
The Korea Pharmaceutical Manufacturers Association (KPMA) plans to recruit an ex-policymaker to fill its biodrug department head seat in September.
The association hired Lee Kyung-ho and Kim Yeon-pan as chairman an...
Sanofi-Aventis Korea to collaborate with 4 university hospitals for clinical trials
Sanofi-Aventis Korea said Monday it has signed a memorandum of understanding (MOU) with four local university hospitals, such as Samsung Medical, Center, Seoul National University, Hospital, Asan Medical Center and Se...
Pharmaceutical lobby groups calling for abolition of cash incentive system
The country’s five drug organizations have called on the government to scrap the controversial cash incentive system for doctors and pharmacists, claiming that pharmaceutical companies here will collapse if the govern...
Takeda to beep up oncology business
Takeda Pharmaceutical Co. has recently unveiled its firm commitment to becoming a global leader in oncology until 2012 by delivering novel therapies that improve the standards of care for patients.it was learned on Mo...
Ildong to release another Aronamin product
Ildong Pharmaceutical Co. will roll out a new-type Aronamin product containing lots of nutrients, including calcium and ursodeoxycholic acid.
The drug maker said Monday the Korea Food and Drug Administration has ap...
Korea readies for Bio Korea 2012 Conference and Exhibition
The Korea Health Industry Development Institute (KHIDI) and North Chungcheong are set to hold Bio Korea 2012 Conference and Exhibition in Gyunggi Province, Korea from September 12–14, 2012 at Ilsan’s Kintex.
Bio Ko...
BMS to beef up portfolio of diabetes medicines
U.S. based Bristol-Myers Squibb (BMS) is set to increase and promote its innovative portfolio of diabetes medicines, extending its reach across the spectrum of treatment options.
Both BMS and AstraZeneca successful...
Wholesalers desperate to keep their margin profits
These days, pharmaceutical wholesalers are feeling pressure from pharmaceutical firms who want to slash the wholesaler’s margin profits amid an aggravating business atmosphere.
“Most companies complained that they ...
Future of KPMA’ biopharmaceutical department
As the head of biopharmaceutical department in the Korea Pharmaceutical Manufacturers Association is going to resign in September, all eyes are on the association’s decision on whether it will push forward with the de...
